Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 813 results for "bristol myers squibb"

Bristol-Myers Squibb (BMY) Stock Price Target Increased at BMO
TheStreet.com

BRISTOL MYERS SQUIBB : Recent Findings from Bristol-Myers Squi...

Recent Findings from Bristol-Myers Squibb Provides New Insights into Pharmaceutical Science (Real-Time Assessment of Granule Densification in High Shear Wet Granulation and Application to Scale-up of a Placebo and a Brivanib Alaninate ...) By a ... 4 Traders, 3 days ago
[x]  

84 images for bristol myers squibb

Irish Times, 1 month ago
Augusta Chronicle, 1 month ago
OncLive, 4 weeks ago
Jutia Group, 1 month ago
Pharmafocus, 2 weeks ago
KPCB, 1 month ago
Pharma Letter, 1 month ago
USA Today, 2 weeks ago
Orthopedics Today, 1 week ago
Jutia Group, 1 month ago

Bristol-Myers Squibb Falls 2.80% on Heavy Volume: Watch For Potential Rebound

Bristol-Myers Squibb (NYSE:BMY) traded in a range yesterday that spanned from a low of $65.54 to a high of $67.26. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $67.29 on volume of 10.5 million shares. Often ...
 Individual.com4 days ago SmarTrend Watching for Potential Rebound in Shares of Bristol-Myers Squibb After 2.80% Loss  Individual.com4 days ago Watch for Bristol-Myers Squibb to Potentially Pullback After Gaining 1.73% Yesterday  Individual.com1 week ago
Citybizlist

Bristol-Myers buys global license to discovery research programme focused on autoimmune diseases from Novo Nordisk

Bristol-Myers Squibb Company, a global biopharmaceutical company, has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research programme focused on modulating ...
 PharmaBiz4 days ago Bristol-Myers Squibb nabs exclusive license for autoimmune diseases discovery research program from Novo Nordisk  Seeking Alpha5 days ago Bristol-Myers Squibb Assigned AA- Credit Rating by Morningstar (BMY)  SleekMoney4 days ago Bristol-Myers Squibb signs licensing deal with Novo Nordisk  Manufacturing Chemist4 days ago
[x]  

Pembrolizumab Bests Ipilimumab in Melanoma Trial

Pembrolizumab ( Keytruda , Merck) has bested ipilimumab ( Yervoy , Bristol-Myers Squibb) in the treatment of advanced melanoma in a head-to-head clinical trial, according to an announcement today from Merck. Pembrolizumab demonstrated a ...
 Dermatology Online Journal4 days ago Merck's Keytruda tops Bristol-Myers' Yervoy in melanoma trial  Seeking Alpha5 days ago Merck & Co.'s Keytruda bests Bristol-Myers Squibb's Yervoy in advanced melanoma study  FirstWord Pharma5 days ago Keytruda beats Yervoy and edges ahead of Opdivo in first-line melanoma  Scrip4 days ago

24.4% Return Seen to Date on SmarTrend Bristol-Myers Squibb Call (BMY)

SmarTrend identified an Uptrend for Bristol-Myers Squibb (NYSE:BMY) on October 22nd, 2014 at $51.99. In approximately 5 months, Bristol-Myers Squibb has returned 24.45% as of today's recent price
 Individual.com3 days ago 30.0% Return Seen to Date on SmarTrend Bristol-Myers Squibb Call (BMY)  Individual.com1 week ago

Potential Bristol Myers (BMY) Trade Has 4.12% Downside Protection

The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center Aare highlighting two trades on Bristol-Myers Squibb Co (http://www.marketintelligencecenter.com/symbol/BMY"BMY) today after it ...
 Individual.com6 days ago
Pharma Letter

Bristol-Myers acquires rights to Novo Nordisk program focused on autoimmune diseases24-03-2015

US pharma major Bristol-Myers Squibb has agreed to acquire from Danish diabetes care giant Novo Nordiskā€¦ In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login , ...
 Pharma Letter4 days ago Bristol-Myers buys rights to Novo Nordisk immune system project  CNBC5 days ago REUTERS - Bristol-Myers buys rights to Novo Nordisk immune system project  Namibia Press Agency5 days ago
[x]  

Bristol-Myers Squibb Looks to Continue to Trade Above its Annual-High Share Price Today

(Financial News NetwFork O) Shares of Bristol-Myers Squibb (NYSE:BMY) traded at a new 52-week high today of $69.20. So far today approximately 4.6 million shares have been exchanged, as compared to an average 30-day volume of 6.1 million shares. ...
 Individual.com1 week ago Bristol-Myers Squibb Sets New 1-Year High at $68.20 (BMY)  WKRB News1 week ago
Comtex SmarTrend

Possible Bearish Inside Day Candle Pattern Detected for Bristol-Myers Squibb (NYSE:BMY)

Written on Tue, 03/17/2015 - 3:06pm By Amy Schwartz SmarTrend's candlestick scanner has spotted a possible bearish inside day candle pattern in Bristol-Myers Squibb ( NYSE:BMY ) based on the price action in the company's shares. Today's price ...
 Comtex SmarTrend1 week ago
Xconomy

Ex-Teva CEO Levin Is Back With Startup Aimed at Rare Neuro Disorders

3/25/15 Follow @benthefidler Jeremy Levin is best known for helping reshape Bristol-Myers Squibb, turning it from a lumbering conglomerate to a leaner oncology drugmaker. Levin parlayed that job into the head seat at Teva Pharmaceutical; there he ...
 Xconomy3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol myers squibb
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less